is glp 1 for women only GLP-1 weight-loss drugs pose hidden risks young GLP-1s are generating a lot

Start your intake FDA Approval Status and Age Restrictions Across GLP-1 Medications The FDA has not approved semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) for patients under 18 years old

Mistake 1: chasing the "perfect" time instead of being consistent This is the most common and most damaging mistake

Combined with topiramate (as Qsymia), results improve to 8-10% average weight loss

Semaglutide GLP-1 typically starts showing noticeable effects within the first 4 to 6 weeks of treatment

Decisions should be based on the patients metabolic health, cardiovascular risk, weight history, medications, family history, and overall clinical picture